Viewpoint: Antimicrobial Resistance Diagnostics Use Accelerator: Qualitative Research on Adherence to Prescriptions
Adélaïde Compaoré, Deborah Ekusai‐Sebatta, David Kaawa–Mafigiri, Vida Kukula, Selase Odopey, James Kapisi, Heidi Hopkins, François Kiemdé, Halidou Tinto, Rita Baiden, Piero Olliaro, Juvenal Nkeramahame, Sabine Dittrich, Philip Horgan, the ADIP study group, Phyllis Awor, Deborah Ekusai-Sebatta, Heidi Hopkins, David Kaawa–Mafigiri, James Kapisi, Freddy Eric Kitutu, Elizeus Rutebemberwa, Asadu Sserwanga, Alexander Adjei, Rita Baiden, Vida Kukula, Adélaïde Compaoré, François Kiemdé, Halidou Tinto, Daniel Valia
Abstract
In this Viewpoint, the authors explore the determinants of patients' prescription adherence behaviors as part of FIND's Advancing Access to Diagnostic Innovation essential for Universal Health Coverage and AMR Prevention (ADIP) trials (ClinicalTrials.gov identifier: NCT04081051). Research findings from Burkina Faso, Ghana, and Uganda show that basic knowledge and understanding of prescription instructions are essential for adherence and can be improved through better communication. However, there are a range of other factors that influence adherence, some of which can be influenced through tailored communication messages from healthcare workers. These messages may contribute to changes in adherence behavior but may require other reinforcing interventions to be effective. Finally, there are some drivers of nonadherence centered around costs and time pressure that require other forms of intervention.